Sector ratings Charles River Laboratories International, Inc.

Stocks

Market Closed - NYSE Other stock markets 04:00:02 2026-07-27 pm EDT			After hours 07:15:01 am
224.30 ^USD	-1.01%		228.60	+1.91%

Jul. 20	Analyst recommendations: Global Payments, Charles Schwab, US Bancorp, Datadog, Netflix…
Jul. 13	BofA Adjusts Price Target on Charles River Laboratories International to $264 From $220	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	10.8B		AA
LONZA GROUP AG	47.74B		AAA
REVOLUTION MEDICINES, INC.	39.98B	-	B	-	-
BEONE MEDICINES AG	36.23B		-
IQVIA HOLDINGS INC.	35.59B		AAA
CELLTRION, INC.	27.91B		A
ASCENDIS PHARMA A/S	16.71B	-	-	-	-
MEDPACE HOLDINGS, INC.	16.45B		BBB
EUROFINS SCIENTIFIC SE	13.21B		AA
ICON PUBLIC LIMITED COMPANY	12.93B		AAA
BIO-TECHNE CORPORATION	11.16B		AA
ABIVAX	11.1B	-	BBB	-	-
APOGEE THERAPEUTICS, INC.	10.08B	-	B	-	-
PHARMARON BEIJING CO., LTD.	9.54B		AA
IONIS PHARMACEUTICALS, INC.	9.25B	-	A	-	-
KYMERA THERAPEUTICS, INC.	9.05B	-	BBB	-	-
PRAXIS PRECISION MEDICINES, INC.	8.8B	-	B	-	-
ALKERMES PLC	8.79B		A
PROTAGONIST THERAPEUTICS, INC.	8.72B		BB		-
QIAGEN N.V.	8.5B		AAA
Average	17.63B		A
Weighted average by Cap.			A